Search

Bevacizumab (Avastin®) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer, according to a new study. Results from the phase III "OCEANS" trial were presented today by the lead author, Carol Aghajanian, MD, of Memorial Sloan Kettering Cancer Center, at the 2011 annual meeting of the American Society of Clinical Oncology.

… Saturday, June 4, 2011 Bevacizumab (Avastin®) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer , according to a new study. Results from the phase III “OCEANS” trial were presented today by the lead author, Carol Aghajanian, MD , of Memorial Sloan

The FDA has approved an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials resulting in the drug’s approval were led by Dr. Sandra D’Angelo of MSK.

… Friday, August 2, 2024 The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleucel (Tecelra ® , also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called  synovial sarcoma . Afami-cel is the first engineered

MSK molecular geneticist and data scientist Elli Papaemmanuil is leading an initiative to identify the genomic changes that drive pediatric tumors.

… Monday, September 30, 2019 Summary About half of pediatric tumors have a significant mutation that can be identified with standard clinical tests. MSK researchers are looking for a better way to detect mutations in the rest. MSK-IMPACT ™ detects changes in more than 400 cancer-associated genes. The test

New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.

… Friday, May 24, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies. Anti-ceramide immunotherapy promising against

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering Cancer Center.

… Thursday, July 10, 2008 Blake Aims to Raise $1 Million for the Fund in Its Inaugural American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering

Brain cancer is deadly because it’s so difficult to study. Scientist Luis Parada has developed an innovative model to analyze how brain tumors form and respond to treatment.

… Friday, January 1, 2021 Finding a treatment for brain tumors like glioblastoma (GBM) has been a heartbreaking challenge. The five-year survival rate is less than 10% for patients 45 and older. Because these tumors are relatively rare and located in such a sensitive and well-sheltered part of the body

Researchers have discovered a genetic mechanism that may trigger most childhood cancers.

… Monday, May 15, 2017 Summary Researchers have found that a gene called PGBD5 plays a role in causing many pediatric cancers by creating mutations that turn cells malignant. Cancer is primarily a disease of the aged. A person’s risk rises throughout the years as genetic mutations pile up, due either to

David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments.

… Tuesday, May 27, 2014 Summary David Solit, Director of the Marie-Josée and Henry R. Kravis Center for Molecular Oncology, discusses how working with cancer patients drives him to develop more-effective, personalized cancer treatments. David Solit became a doctor because he wanted to care for patients

A team of scientists is combining sophisticated chemistry and experiments in zebrafish to develop a new cancer drug that shows early potential against melanoma and metastatic breast cancer.

… Monday, June 22, 2015 Summary A growing community of Memorial Sloan Kettering scientists are doing research into  epigenetics  — an intricate system of biochemical adjustments that cells use to regulate genes — to improve our understanding of cancer and other diseases. One of these researchers is Mingkui

A visionary program investigates how the body’s ecosystem affects cancer.

… Friday, April 1, 2022 Dear MSK Community,   We are poised at a pivotal moment in cancer research.   For the past few decades, researchers have focused on identifying gene mutations associated with cancer and have developed highly effective drugs to target them. This revolutionary approach, called precision